Clinical Trials in San Francisco

Showing 6821-6840 of 9,883 trials

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

NCT00090987

RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking the enzymes necessary for their growth. PURPOSE: This phase II trial is studying how well imatinib mesylate works in treating patients with HIV-related Kaposi's sarcoma.

Sarcoma

AIDS Malignancy Consortium30 participantsStarted Jun 2005

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

NCT00392834

RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving rituximab together with combination chemotherapy may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving rituximab together with combination chemotherapy works in treating patients with newly diagnosed, HIV-associated Burkitt's lymphoma.

Lymphoma

AIDS Malignancy Consortium34 participantsStarted Sep 2006

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +10 more locations

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

Find Trials by Condition in San Francisco

OLIF25™ /OLIF51™ Study

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

Remotely Deployed TBI Study

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

Impact of a Mobile Application (Pacifica) on Stress, Anxiety, and Depression

Phoenix Exoskeleton for SCI Users

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders

Thrombolysis in Pediatric Stroke (TIPS)

Reversal of Hypoglycemia Unawareness Using Continuous Glucose Monitoring

Parents Workgroup About Emotion Regulation

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures